- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02036931
A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System
Study Overview
Status
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France
- Clermont-Ferrand Hospital
-
-
-
-
-
Würzburg, Germany
- University of Würzburg, Orthopedic
-
-
-
-
-
Limerick, Ireland
- Midwestern Regional Orthopaedic Hospital
-
-
-
-
-
Delft, Netherlands
- Reinier de Graaf Groep
-
-
-
-
-
Ponferrada, Spain
- Hospital El Bierzo
-
-
-
-
Arizona
-
Tucson, Arizona, United States, 85718
- University Orthopedic Specialists
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis
- Rheumatoid arthritis
- Correction of functional deformity
- Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques
- Revision procedures where other treatment or devices have failed
- 18 years of age or older
- Subjects willing to return for follow-up evaluations
Exclusion Criteria:
- Infection, sepsis and osteomyelitis
- Subjects unable to cooperate with and complete the study
- Neurological conditions affecting movement
- Pregnancy
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Metal on Polyethylene articulation
G7 cup with Metal on Polyethylene articulation (MOP)
|
G7 Acetabular Cup System with Metal head on Polyethylene liner articulation (MOP)
Other Names:
|
Ceramic on Polyethylene articulation
G7 cup with Ceramic on Polyethylene articulation (COP)
|
G7 Acetabular Cup System with Ceramic head on Polyethylene liner articulation (COP)
Other Names:
|
Ceramic on Ceramic articulation
G7 cup with Ceramic on Ceramic articulation (COC)
|
G7 Acetabular Cup System with Ceramic head on Ceramic linear articulation (COC) - Outside the United States ONLY
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Harris Hip Score
Time Frame: 2 Year post-operative
|
The Harris Hip Scale (HHS) was developed to assess the results of hip surgery, and is intended to evaluate various hip disabilities and methods of treatment in adults. The original version was published 1969. The HHS is an outcome measure administered by a qualified health care professional, such as a physician or a physical therapist. The HHS is a measure of dysfunction so the higher the score, the better the outcome for the individual. The maximum score possible is 100. Results can be interpreted with the following: <70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent. |
2 Year post-operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oxford Hip Score
Time Frame: 1 Year post-operative
|
The Oxford Hip Score (OHS) is a standard patient-reported outcome measure tool designed to assess function and pain in patients undergoing total hip replacement (THR).
Each item has five possible responses.
Responses go from 1 = least difficult to 5= most difficult.
Item scores are summed to give a total score from anywhere between 12 and 60.
The lower the score, the better the outcome.
|
1 Year post-operative
|
Oxford Hip Score
Time Frame: 2 Year post-operative
|
The Oxford Hip Score (OHS) is a standard patient-reported outcome measure tool designed to assess function and pain in patients undergoing total hip replacement (THR).
Each item has five possible responses.
Responses go from 1 = least difficult to 5= most difficult.
Item scores are summed to give a total score from anywhere between 12 and 60.
The lower the score, the better the outcome.
|
2 Year post-operative
|
Oxford Hip Score
Time Frame: 5 Year post-operative
|
The Oxford Hip Score (OHS) is a standard patient-reported outcome measure tool designed to assess function and pain in patients undergoing total hip replacement (THR).
Each item has five possible responses.
Responses go from 1 = least difficult to 5= most difficult.
Item scores are summed to give a total score from anywhere between 12 and 60.
The lower the score, the better the outcome.
|
5 Year post-operative
|
Radiographic Evaluation
Time Frame: 1 Year post-operative
|
Radiolucencies (mm), Stability, Angle of Inclination (degree). The degree of osseous-fixation will be graded using the following system; 0-1mm radiolucencies will be classed as fixated; >1-2mm radiolucencies will be classed as not fixated; >2mm radiolucencies will be classed as unstable. If more than 50% of the 3 zones have radiolucencies of greater than 1mm, then the implant is considered not to be well fixed. The angle of Inclination is the angle between the plane of the acetabular cup and the transichial line. |
1 Year post-operative
|
Radiographic Evaluation
Time Frame: 2 Year post-operative
|
Radiolucencies (mm), Stability, Angle of Inclination (degree). The degree of osseous-fixation will be graded using the following system; 0-1mm radiolucencies will be classed as fixated; >1-2mm radiolucencies will be classed as not fixated; >2mm radiolucencies will be classed as unstable. If more than 50% of the 3 zones have radiolucencies of greater than 1mm, then the implant is considered not to be well fixed. The angle of Inclination is the angle between the plane of the acetabular cup and the transichial line. |
2 Year post-operative
|
Radiographic Evaluation
Time Frame: 5 Year post-operative
|
Radiolucencies (mm), Stability, Angle of Inclination (degree). The degree of osseous-fixation will be graded using the following system; 0-1mm radiolucencies will be classed as fixated; >1-2mm radiolucencies will be classed as not fixated; >2mm radiolucencies will be classed as unstable. If more than 50% of the 3 zones have radiolucencies of greater than 1mm, then the implant is considered not to be well fixed. The angle of Inclination is the angle between the plane of the acetabular cup and the transichial line. |
5 Year post-operative
|
Survivorship
Time Frame: 7 Year post-operative
|
Questionnaire
|
7 Year post-operative
|
Survivorship
Time Frame: 10 Year post-operative
|
Questionnaire
|
10 Year post-operative
|
Adverse Events
Time Frame: Up to 10 years postoperatively
|
Adverse events will be documented according to ISO 14155:2011 definitions previously described.
For the purposes of this study, only adverse events meeting SAE, ADE, SADE, and USADE criteria will be included, unless otherwise reported at the discretion of the investigator.
|
Up to 10 years postoperatively
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Hassan Achakri, PhD, Zimmer Biomet
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ORTHO.CR.GH20.13
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
National Institute of Arthritis and Musculoskeletal...Children's Hospital Medical Center, CincinnatiCompleted
-
University of PittsburghNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedRheumatoid Arthritis | Juvenile Rheumatoid ArthritisUnited States
-
University of Missouri-ColumbiaCompletedJuvenile Rheumatoid ArthritisUnited States
-
Assistance Publique - Hôpitaux de ParisSociete Francaise de RhumatologieRecruiting
-
Amsterdam UMC, location VUmcEuropean CommissionCompletedRheumatoId ArthritisNetherlands, Germany, Portugal, Italy, Hungary, Romania, Slovakia
Clinical Trials on Metal on Polyethylene articulation
-
Zimmer BiometTerminatedOsteoarthritisBosnia and Herzegovina, South Africa
-
Korea University Guro HospitalUnknownHip Replacement ArthroplastyKorea, Republic of
-
Sahlgrenska University Hospital, SwedenStryker NordicUnknown
-
Biomet Orthopedics, LLCWithdrawnArthritis | Osteoarthritis | Rheumatoid Arthritis | Traumatic Arthritis
-
Nova Scotia Health AuthorityUniversity Health Network, TorontoTerminatedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Ankylosing Spondylitis | Post-traumatic; Arthrosis | Congenital Dysplasia of the Hip | Injury of Hip and Thigh
-
Zimmer BiometActive, not recruitingOsteoarthritisFinland, United Kingdom
-
Zimmer BiometActive, not recruitingOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Inflammatory Arthritis | Post-traumatic ArthritisUnited States
-
Zimmer BiometBiomet U.K. Ltd.CompletedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Traumatic ArthritisUnited Kingdom
-
Hospices Civils de LyonMINAPATH DéveloppementRecruiting